Automated & Closed Cell Therapy Processing System Market Outlook

The automated and closed cell therapy processing system market is expected to expand at a 22.8% CAGR from 2023 to 2033. This market is estimated to value from US$ 1,199.14 million in 2023 to US$ 9,350.92 million in 2033.

Increasing Integration of Software Technologies and Sophisticated Therapy Development Procedures is also Expected to Drive Market Growth

For controlling and sustaining the cell therapy process, automated and closed cell therapy processing systems are used. The system includes manufacturing software and hardware, which aids in the entire research and development process. The technology is a gift to researchers because it assists them in clinical studies through commercial approval. This can aid in the development and avoidance of manual manufacturing delays. Several scale levels of standardisation can be accomplished for diverse production processes.

Researchers believe automated and closed cell therapy processing systems to be simple to use and dependable, as they aid in converting cell therapy from discovery to commercialization.

The increasing number of investments in the market for automated and closed cell therapy processing systems is the key driver of market expansion in the next years. Furthermore, the growing number of cell therapies provides the market with profitable potential. Cell treatment processing is a critical activity that necessitates extreme precision while treating the cells.

The usage of physical labor has been determined to be inefficient because it increases the risk of the process. Also, manual processing increases the possibility of contamination. As a result, the combination of advanced medicines and automated systems is quickly rising.

The adoption of automated systems has aided in the centralization of cell therapy processes, which has benefited manufacturers in a variety of ways.

Report Attribute Details
Automated and Closed Cell Therapy Processing System Market Value (2023) US$ 1199.14 million
Automated and Closed Cell Therapy Processing System Market Anticipated Value (2033) US$ 9350.92 million
Automated and Closed Cell Therapy Processing System Market Growth Rate (2023 to 2033) 22.8% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Automated and Closed Cell Therapy Processing System Market Outlook in Comparison to 2023 to 2033 Growth Forecast

The automated and closed cell therapy processing system market accounted for US$ 976.50 million in 2022, expanding at a 22.4% CAGR from 2018 to 2022.

Cell therapy technologies are critical in medicine and the cell therapy sector, which has arisen as a crucial factor in medical practice. Furthermore, various cell treatment approaches share functions such as medication delivery, gene therapy, cancer vaccinations, tissue engineering, and regenerative medicine. The distribution of cell therapy products can range from injections to surgical implantation using specialized equipment.

The increasing popularity of regenerative medicines and cell therapies is one of the important factors driving the market growth. The multiple advantages afforded by automation technologies for the development of these therapies are further driving market expansion. Furthermore, the increasing mix of software technologies and complex therapy development techniques is bolstering the market growth.

Historical CAGR (2018 to 2022) 22.4%
Forecast CAGR (2023 to 2033) 22.8%

As per the FMI analysts, a valuation of US$ 9350.92 million by 2033 end is estimated for the market.

Year Market Valuation
2016 US$ 284.76 million
2021 US$ 795.20 million
2022 US$ 976.50 million
2023 US$ 1199.14 million
2033 US$ 9350.92 million

Comparative Analysis of Adjacent Markets

Automated and Closed Cell Therapy Processing System Market:

Differentiating Aspects Automated and Closed Cell Therapy Processing System Market
Anticipated CAGR (2023 to 2033) 22.8%
Market Valuation (2023) US$ 1199.14 million
Growth Factors The market is being boosted by the variety of benefits provided by automation technologies, as well as an increasing number of technological developments linked with cell therapy processing.
Future Opportunities Rising investments by bio manufacturers in the development of cellular treatment products via a series of funding rounds are expected to provide attractive prospects to enter the industry.
Market Trends Clinical trials for innovative medicines are expected to skyrocket in the coming years. As a result of this expansion, there is a great demand for innovative and automated technologies that produce high throughput and yield.

Cell Therapy Market:

Differentiating Aspects Cell Therapy Market
Anticipated CAGR (2023 to 2033) 14.17%
Market Valuation (2023) US$ 24.66 million
Growth Factors The increase in financing for cell therapy clinical trials, as well as the development of relevant guidelines for cell therapy manufacturing, are some of the primary drivers impacting the market growth.
Future Opportunities The cell treatment market is constantly expanding to encompass new cell types, creating a huge opportunity for companies to increase their market positions.
Market Trends Some of the primary causes driving expansion are physicians' increased propensity toward the therapeutic use of allogeneic therapies and rising awareness regarding the use of cord cells and tissues across numerous therapeutic sectors.

Lung Cancer Therapeutics Market:

Differentiating Aspects Lung Cancer Therapeutics Market
Anticipated CAGR (2023 to 2033) 13.2%
Market Valuation (2023) US$ 34067.30 million
Growth Factors Increasing demand for tailored therapeutics might drive market expansion.
Future Opportunities The increasing prevalence of lung cancer and other chronic diseases has fueled the usage of lung cancer therapies in both emerging and developed countries.
Market Trends Increased research and development in the field of lung cancer therapies are also promoting their rise.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Increasing Interest in Regenerative Medicine

Regenerative medicine is a branch of medicine that involves the replacement of damaged tissues or organs. Regenerative medicine is concerned with replacing and rebuilding tissue or organ damage caused by a specific disease or event.

The growing importance of stem cells in regenerative medicine results in increasing demand for regenerative medicine from the healthcare industry. This factor remains a significant factor driving the creation of automated and closed-cell therapy processing systems.

Cancer and other chronic diseases that require long-term therapy have increased the popularity of regenerative medicine. Stem cell uses are part of regenerative medicine. Stem cells can be divided indefinitely and are employed as a first-line source for regenerative therapy.

Regenerative medicine is a branch of medicine that uses various methods to repair, regrow, or replace diseased or damaged cells, organs, or tissues. Furthermore, regenerative medicine encompasses the synthesis and application of therapeutic stem cells, tissue development, and the creation of artificial organs. Due to their high accuracy and effectiveness, regenerative medicines and cell therapies are expected to see a surge in demand, driving the market growth.

Chronic Disease Prevalence is Increasing

Chronic disease refers to a category of diseases that include cardiovascular disease, cancer, and diabetes, among others. The global population is experiencing an increase in the prevalence of chronic diseases. It is primarily linked to sedentary behavior, an unhealthy diet, and cigarette use.

Chronic disease, according to the USA Centers for Disease Control and Prevention (CDC), is a condition that lasts longer than a year. This disease requires prompt medical attention. It limits everyday activities also.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Scarcity of Trained Professionals

As cell therapies become popular, the market for automated processing systems needs experienced personnel to perform these therapies and operate automated systems. The shortage of skilled specialists, on the other hand, is expected to stymie the expansion of the automated and closed cell therapy processing system market over the forecast period.

The use of technologically advanced and extremely intricate flow cytometers and spectrophotometers to generate a large number of data outputs that require knowledge to comprehend and assess might impede the market growth.

Raw Material Scarcity

The complete cell therapy manufacturing process is made up of several phases, each of which requires a starting material. The global need for automated and closed-cell therapy processing systems has resulted in a scarcity of raw materials required for good medical practice (GMP).

The market is experiencing a bottleneck in the supply of plasmids and viral vectors, which are proven GMP-based raw materials necessary in the cell therapy process.

The difficulties in procuring starting materials such as bone marrow, blood, and apheresis provide a hindrance to the market's expansion. As a result, the global automated and closed-cell therapy processing system market is constrained by a scarcity of raw materials.

Increasing Pharmaceutical Research and Development Activities

Governments and big pharmaceutical corporations are investing in research and development to accelerate the discovery of new therapies for a variety of health ailments. Increasing research and development investment in cell therapy research might promote market expansion by facilitating the discovery of novel automated and closed-cell therapies.

Increased research and development efforts in the pharmaceutical sector are expected to provide significant income for the market.

A Glimpse of Country-wise Insights

The United States of America Automated and Closed Cell Therapy Processing System Market Analysis

The United States of America with a CAGR of 20.7% from 2015 to 2021 is the prominent market for automated and closed cell therapy. The market for automated and closed cell therapy processing systems in the United States of America is expected to cross US$ 2.2 million by the end of 2032 with an absolute dollar opportunity of US$ 1.9 Million.

The United Kingdom Automated and Closed Cell Therapy Processing System Market Analysis

The market in the United Kingdom is expected to reach a valuation of US$ 312 million by 2032. Growing at a CAGR of 21.2%, the market in the country is projected to cross an absolute dollar opportunity of US$ 155.3 million from 2022 to 2032.

Japan Automated and Closed Cell Therapy Processing Systems Market Analysis

In Japan, the market is projected to register a CAGR of 24.1% during the forecast period. With an absolute dollar opportunity of US$ 262 million from 2022 to 2032, the market in the country is expected to reach US$ 296 million by 2032.

South Korea Automated and Closed Cell Therapy Processing Systems Market Analysis

The market in South Korea is expected to reach US$ 193 million by 2032. With a CAGR of 26.1% during the forecast period, the market is expected to register an absolute dollar opportunity of US$ 173 Million.

Category-Wise Insights

The Separation Segment is Expected to Increase Profitably

The separation workflow category is predicted to expand significantly in the automated and closed-cell therapy processing system market. Separation is an important component of the closed-cell therapy processing system.

Separation of cell components is required for doing the research in a timely manner. The cell separation revealed minute data about genetic modification, molecular analysis, hybridoma creation, and so on. As a result, cell separation is critical for future research and development in research and academic contexts.

Why Non-stem Cell Therapy is Gaining the Utmost Traction when Compared with Other Types?

The market for the Non-Stem Cell Therapy type expanded at a CAGR of 17.2% from 2015 to 2021. The success of CAR-T therapies has shifted investment to non-stem cell therapy development, resulting in increased revenue for the industry.

Companies in the market are hugely collaborating and forming partnerships in order to create new regenerative therapies for the treatment of chronic diseases. Such research efforts are primarily focused on non-stem cell uses, which is fueling the non-stem cell treatment segment's expansion.

The enormous therapeutic potential of cell and tissue-based engineering is predicted to allow the segment to increase at a notable rate during the forecast period.

Competitive Landscape

Some of the recent developments of automated and closed cell therapy processing System Market providers are as follows:

  • In February 2021, Cytiva and Brooks Life Sciences agreed to expand the automated cold chain's capabilities.
  • In October 2021, Terumo worked with BioCentriq Laboratories, a cell, and gene therapy trial manufacturing facility. This collaboration is expected to bring together the companies' respective automation and CDMO knowledge, products, and talents.
  • In August 2020, Lonza and IsoPlexis, a life science technology company, collaborated. The goal of this collaboration was to advance cell therapy manufacturing.

Key Companies Operating in the Market

  • Miltenyi Bio tec
  • Lonza
  • Fresenius Kabi
  • Cytiva
  • Bio Spherix
  • Terumo
  • Cellares
  • Sartorius

Scope of Report

Attribute Details
Market Size Value In 2023 US$ 1199.14 million
Market Size Value in End of Forecast (2033) US$ 9350.92 million
Market Analysis US$ million for Value
Key Region Covered North America; Europe; Asia Pacific; Latin America; The Middle East & Africa
Key Segments By Type, By Workflow, By Scale, By Region
Key Companies Profiled Miltenyi Bio tec; Lonza; Fresenius Kabi; Cytiva; Bio Spherix; Terumo; Cellares; Sartorius
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Automated and Closed Cell Therapy Processing System Market Key Segmentation

By Type:

  • Stem Cell Therapy
  • Non-Stem Cell Therapy

By Workflow:

  • Separation
  • Expansion
  • Apheresis
  • Fill-Finish
  • Cryopreservation

By Scale:

  • Pre-commercial/Research and Development Scale
  • Commercial Scale

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the Present Automated and Closed Cell Therapy Processing Systems Market Size?

The automated and closed cell therapy processing systems market size will reach US$ 1199.14 million in 2023.

What Size is the Automated and Closed Cell Therapy Processing Systems Market Expected to Reach by 2033?

The automated and closed cell therapy processing systems market is set to surge at a robust 22.8% CAGR, reaching a noteworthy valuation of US$ 9350.92 million by 2033.

What was the Automated and Closed Cell Therapy Processing Systems Market's Past Record like?

The automated and closed cell therapy processing systems market demonstrated a 22.4% CAGR from 2018 to 2022, recording a valuation of US$ 976.50 million in 2022

What Key Opportunities does the Automated and Closed Cell Therapy Processing Systems Market Present for Stakeholders?

The automated and closed cell therapy processing systems market beckons stakeholders with opportunities in innovative medical technologies.

Which Segment Accounted for the Leading Automated and Closed Cell Therapy Processing Systems Market Size By Type?

The non-stem cell therapy type demonstrated significant expansion, registering a robust CAGR of 17.2% between 2015 and 2021.

Table of Content

1. Executive Summary | Automated and Closed Cell Therapy Processing System Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033

        5.3.1. Cryopreservation

        5.3.2. Fill-finish

        5.3.3. Separation

        5.3.4. Expansion

        5.3.5. Apheresis

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033

        6.3.1. Stem Cell Therapy

        6.3.2. Non-stem Cell Therapy

    6.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Scale

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Scale, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Scale, 2023 to 2033

        7.3.1. Commercial Scale

        7.3.2. R&D Scale

    7.4. Y-o-Y Growth Trend Analysis By Scale, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Scale, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Workflow

        9.2.3. By Type

        9.2.4. By Scale

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Workflow

        9.3.3. By Type

        9.3.4. By Scale

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Workflow

        10.2.3. By Type

        10.2.4. By Scale

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Workflow

        10.3.3. By Type

        10.3.4. By Scale

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Workflow

        11.2.3. By Type

        11.2.4. By Scale

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Workflow

        11.3.3. By Type

        11.3.4. By Scale

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Workflow

        12.2.3. By Type

        12.2.4. By Scale

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Workflow

        12.3.3. By Type

        12.3.4. By Scale

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Workflow

        13.2.3. By Type

        13.2.4. By Scale

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Workflow

        13.3.3. By Type

        13.3.4. By Scale

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Workflow

        14.2.3. By Type

        14.2.4. By Scale

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Workflow

        14.3.3. By Type

        14.3.4. By Scale

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Workflow

        15.2.3. By Type

        15.2.4. By Scale

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Workflow

        15.3.3. By Type

        15.3.4. By Scale

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Workflow

            16.1.2.2. By Type

            16.1.2.3. By Scale

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Workflow

            16.2.2.2. By Type

            16.2.2.3. By Scale

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Workflow

            16.3.2.2. By Type

            16.3.2.3. By Scale

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Workflow

            16.4.2.2. By Type

            16.4.2.3. By Scale

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Workflow

            16.5.2.2. By Type

            16.5.2.3. By Scale

    16.6. United kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Workflow

            16.6.2.2. By Type

            16.6.2.3. By Scale

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Workflow

            16.7.2.2. By Type

            16.7.2.3. By Scale

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Workflow

            16.8.2.2. By Type

            16.8.2.3. By Scale

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Workflow

            16.9.2.2. By Type

            16.9.2.3. By Scale

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Workflow

            16.10.2.2. By Type

            16.10.2.3. By Scale

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Workflow

            16.11.2.2. By Type

            16.11.2.3. By Scale

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Workflow

            16.12.2.2. By Type

            16.12.2.3. By Scale

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Workflow

            16.13.2.2. By Type

            16.13.2.3. By Scale

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Workflow

            16.14.2.2. By Type

            16.14.2.3. By Scale

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Workflow

            16.15.2.2. By Type

            16.15.2.3. By Scale

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Workflow

            16.16.2.2. By Type

            16.16.2.3. By Scale

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Workflow

            16.17.2.2. By Type

            16.17.2.3. By Scale

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Workflow

            16.18.2.2. By Type

            16.18.2.3. By Scale

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Workflow

            16.19.2.2. By Type

            16.19.2.3. By Scale

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Workflow

            16.20.2.2. By Type

            16.20.2.3. By Scale

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Workflow

            16.21.2.2. By Type

            16.21.2.3. By Scale

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Workflow

        17.3.3. By Type

        17.3.4. By Scale

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Lonza

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. BioSpherix

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Cellares

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Sortorius

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Cytiva

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. ThermoGenesis Holdings Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Thermo Fisher Scientific Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. MiltenyiBiotec

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Fresenius Kabi

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Pfizer

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Automated and Closed Cell Therapy Processing Systems Market